Statin Discontinuation and Life-Limiting Illness in Non-Skilled Stay Nursing Homes at Admission.

ABSTRACT:

Objectives

To estimate 30-day statin discontinuation among newly admitted nursing home residents overall and within categories of life-limiting illness.

Design

Retrospective cohort using Minimum Data Set 3.0 nursing home admission assessments from 2015 to 2016 merged to Medicare administrative data files.

Setting

U.S. Medicare- and Medicaid-certified nursing home facilities (n = 13,092).

Participants

Medicare fee-for-service beneficiaries, aged 65 years and older, newly admitted to nursing homes for non-skilled nursing facility stays on statin pharmacotherapy at the time of admission (n = 73,247).

Measurements

Residents were categorized using evidence-based criteria to identify progressive, terminal conditions or limited prognoses (<6 months). Discontinu

SUBMITTER: Mack DS 

PROVIDER: S-EPMC8127623 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature